发布求助
文献互助 智能选刊 最新文献

Drugs of The Future最新文献

筛选
英文 中文
Pipeline on the Move - May 2022 管道在移动- 2022年5月
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.5.3437190
L. Fernández Bertolín
{"title":"Pipeline on the Move - May 2022","authors":"L. Fernández Bertolín","doi":"10.1358/dof.2022.47.5.3437190","DOIUrl":"https://doi.org/10.1358/dof.2022.47.5.3437190","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66443998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
American Society of Clinical Oncology (ASCO) - 58th Annual Meeting. Chicago/Virtual - June 3-7, 2022 美国临床肿瘤学会(ASCO)第58届年会。芝加哥/Virtual - 2022年6月3-7日
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.8.3455365
X. Riu Martinez, R. Bandari, A. Lalitha
{"title":"American Society of Clinical Oncology (ASCO) - 58th Annual Meeting. Chicago/Virtual - June 3-7, 2022","authors":"X. Riu Martinez, R. Bandari, A. Lalitha","doi":"10.1358/dof.2022.47.8.3455365","DOIUrl":"https://doi.org/10.1358/dof.2022.47.8.3455365","url":null,"abstract":"The American Society of Clinical Oncology (ASCO) is the largest oncology organization in the world, comprising nearly 45,000 oncology professionals. This 58th ASCO annual meeting was held from June 3 to 7 in Chicago, where plenary, oral, educational and poster sessions were presented in person and/or virtually due to the COVID-19 pandemic. All sessions discussed different topics related to oncology including data from clinical studies for the treatment of various cancers, updates in cutting-edge cancer research or the current existing treatments and future considerations, and new drugs or treatment options. This congress brought together cancer experts from all over the world operating under the ASCO principle of \"Knowledge conquers cancer\" to try and reach its main goal of preventing or curing cancer and improving the quality of life of cancer patients.","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66445268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Glofitamab. Anti-CD20 T-cell-engaging bispecific antibody, Treatment of non-Hodgkin lymphoma Glofitamab。抗cd20 t细胞结合双特异性抗体，治疗非霍奇金淋巴瘤
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.10.3453463
E. Gaskill, S. Price
{"title":"Glofitamab. Anti-CD20 T-cell-engaging bispecific antibody, Treatment of non-Hodgkin lymphoma","authors":"E. Gaskill, S. Price","doi":"10.1358/dof.2022.47.10.3453463","DOIUrl":"https://doi.org/10.1358/dof.2022.47.10.3453463","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66440669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adagrasib. GTPase KRAS (G12C mutant) inhibitor, Treatment of non-small cell lung cancer, Treatment of colorectal cancer Adagrasib。GTPase KRAS (G12C突变体)抑制剂，治疗非小细胞肺癌，治疗结直肠癌
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.11.3447917
S. Shao, W. Rong, S. Talukder, R. Jia, Z. Chen
{"title":"Adagrasib. GTPase KRAS (G12C mutant) inhibitor, Treatment of non-small cell lung cancer, Treatment of colorectal cancer","authors":"S. Shao, W. Rong, S. Talukder, R. Jia, Z. Chen","doi":"10.1358/dof.2022.47.11.3447917","DOIUrl":"https://doi.org/10.1358/dof.2022.47.11.3447917","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66441193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pipeline on the Move - October 2022 管道在移动- 2022年10月
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.10.3489073
L. Fernández Bertolín
{"title":"Pipeline on the Move - October 2022","authors":"L. Fernández Bertolín","doi":"10.1358/dof.2022.47.10.3489073","DOIUrl":"https://doi.org/10.1358/dof.2022.47.10.3489073","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66441350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nirsevimab. Anti-glycoprotein F (respiratory syncytial virus) monoclonal antibody, Prevention of respiratory syncytial virus-associated illness Nirsevimab。抗糖蛋白F(呼吸道合胞病毒)单克隆抗体，预防呼吸道合胞病毒相关疾病
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.2.3275932
A. Akhir, A. Dasgupta, S. Chopra
{"title":"Nirsevimab. Anti-glycoprotein F (respiratory syncytial virus) monoclonal antibody, Prevention of respiratory syncytial virus-associated illness","authors":"A. Akhir, A. Dasgupta, S. Chopra","doi":"10.1358/dof.2022.47.2.3275932","DOIUrl":"https://doi.org/10.1358/dof.2022.47.2.3275932","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66442710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Zimberelimab. Anti-programmed cell death protein 1 (PD-1) monoclonal antibody, Treatment of Hodgkin lymphoma, Treatment of advanced solid tumors Zimberelimab。抗程序性细胞死亡蛋白1 (PD-1)单克隆抗体，治疗霍奇金淋巴瘤，治疗晚期实体瘤
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.2.3400575
M. Sahu, J. H. Choe
{"title":"Zimberelimab. Anti-programmed cell death protein 1 (PD-1) monoclonal antibody, Treatment of Hodgkin lymphoma, Treatment of advanced solid tumors","authors":"M. Sahu, J. H. Choe","doi":"10.1358/dof.2022.47.2.3400575","DOIUrl":"https://doi.org/10.1358/dof.2022.47.2.3400575","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66443172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Navtemadlin. MDM2-p53 interaction inhibitor, Treatment of cancer Navtemadlin。MDM2-p53相互作用抑制剂，治疗癌症
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.4.3381587
S. Price, A. Al-Bahou
{"title":"Navtemadlin. MDM2-p53 interaction inhibitor, Treatment of cancer","authors":"S. Price, A. Al-Bahou","doi":"10.1358/dof.2022.47.4.3381587","DOIUrl":"https://doi.org/10.1358/dof.2022.47.4.3381587","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66443536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
San Antonio Breast Cancer Symposium 2021 - 44th Annual Meeting. Virtual/San Antonio - December 7-10, 2021 圣安东尼奥乳腺癌研讨会2021 -第44届年会。虚拟/圣安东尼奥- 2021年12月7日至10日
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.4.3421335
P. Sudha
{"title":"San Antonio Breast Cancer Symposium 2021 - 44th Annual Meeting. Virtual/San Antonio - December 7-10, 2021","authors":"P. Sudha","doi":"10.1358/dof.2022.47.4.3421335","DOIUrl":"https://doi.org/10.1358/dof.2022.47.4.3421335","url":null,"abstract":"The 2021 San Antonio Breast Cancer Symposium was run as a hybrid meeting allowing its attendees to participate both in person at the Henry B. Gonzalez Convention Center, San Antonio, Texas, and virtually, taking into consideration the safety of attendees due to the ongoing COVID-19 pandemic. The symposium provided state-of-the-art information on etiology, experimental biology, diagnosis, prevention and treatment of breast cancer, as well as premalignant breast diseases.","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66443565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Positioning of hafnium oxide nanoparticles therapy in cancer treatment 纳米氧化铪在癌症治疗中的定位
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.5.3369189
T. Hernández-Guerrero, B. Doger, J. Luna, I. Azinovich, V. Moreno
{"title":"Positioning of hafnium oxide nanoparticles therapy in cancer treatment","authors":"T. Hernández-Guerrero, B. Doger, J. Luna, I. Azinovich, V. Moreno","doi":"10.1358/dof.2022.47.5.3369189","DOIUrl":"https://doi.org/10.1358/dof.2022.47.5.3369189","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66443803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信